» Articles » PMID: 16156838

Treatment-resistant Depression: Resistant to Definition?

Overview
Specialty Psychiatry
Date 2005 Sep 15
PMID 16156838
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To better define treatment-resistant depression (TRD) so as to assist clinical management and refine treatment guidelines.

Method: In this study, we examine a broad range of clinical variables in depressed patients (n=196) referred to a tertiary referral Mood Disorders Unit (MDU). Information was collected from patients, referrers and assessors over a period of 32 months and included evaluations of treatments, treatment resistance and related variables. Data were analysed across trichotomized 'high', 'low' and 'no' treatment resistance groupings of patients.

Results: A significantly greater proportion of patients with melancholia were amongst the high TRD group, and this was consistent across different strategies for evaluating melancholia.

Conclusion: Melancholia perhaps provides a prototypic TRD subset that perhaps reflects some innate aspects of melancholic depression or factors such as the impact of ageing. Research into TRD is needed to both replicate this finding and perhaps explicate it further.

Citing Articles

Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis.

Junkes L, Gherman B, Appolinario J, Nardi A PLoS One. 2024; 19(5):e0303967.

PMID: 38776336 PMC: 11111054. DOI: 10.1371/journal.pone.0303967.


Rethinking treatment-resistant depression to quasi-tenacious depression.

Arjmand S, Grassi-Oliveira R, Wegener G Eur Psychiatry. 2023; 66(1):e14.

PMID: 36632817 PMC: 9970145. DOI: 10.1192/j.eurpsy.2022.2353.


Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.

Adekkanattu P, Olfson M, Susser L, Patra B, Vekaria V, Coombes B J Affect Disord. 2022; 324:102-113.

PMID: 36529406 PMC: 10327872. DOI: 10.1016/j.jad.2022.12.044.


Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.

Nunez N, Joseph B, Pahwa M, Kumar R, Resendez M, Prokop L J Affect Disord. 2022; 302:385-400.

PMID: 34986373 PMC: 9328668. DOI: 10.1016/j.jad.2021.12.134.


Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine.

Liu L, Golts M, Fernandes V Pharmacy (Basel). 2021; 9(3).

PMID: 34202267 PMC: 8293424. DOI: 10.3390/pharmacy9030118.